Factors Predicting the Axillary Lymph Node Metastasis in Breast Cancer: Is Axillary Node Clearance Indicated in Every Breast Cancer Patient?Factors Predicting the Axillary Lymphnode Metastases in Breast Cancer

被引:0
|
作者
Amrut V. Ashturkar
Gayatri S. Pathak
Sanjay D. Deshmukh
Harshal T. Pandave
机构
[1] Shrimati Kashibai Navale Medical College and General Hospital,Department of Pathology
[2] Shrimati Kashibai Navale Medical College and General Hospital,Department of Community medicine
来源
Indian Journal of Surgery | 2011年 / 73卷
关键词
Breast cancer; Axillary metastases; Histological grade;
D O I
暂无
中图分类号
学科分类号
摘要
The study was carried out to find out predictors of axillary lymph node metastasis in breast cancer and to evaluate its significance in selecting the group of patients in whom axillary dissection could be avoided. Ninety-five breast cancer patients who underwent mastectomy and axillary dissection were included in the study. Factors like patient’s age, tumor size, histopathological type, histological grade and estrogen and progesterone receptor status were correlated with the axillary metastases. Out of 95 cases axillary metastasis was found in 47 (49.47%) cases. There was no correlation between patient’s age and tumor size with axillary metastasis (p > 0.05). Based on histopathological typing tumors like ductal carcinoma in situ, tubular carcinoma and mucinous carcinoma showed less tendency for axillary metastasis (p < 0.046). Association was found between histological grade and estrogen receptor and progesterone receptor positivity with presence of axillary metastasis (p < 0.001 and 0.002 respectively). The findings in this study indicate that breast cancer patients having favorable histological type, grade I tumors and estrogen and progesterone receptor negative tumor are good candidates to avoid axillary dissection.
引用
收藏
页码:331 / 335
页数:4
相关论文
共 50 条
  • [31] Reliability of sentinel node status in predicting axillary lymph node involvement in breast cancer
    Kollias, J
    Gill, PG
    Chatterton, BE
    Hall, VE
    Bochner, MA
    Coventry, BJ
    Farshid, G
    MEDICAL JOURNAL OF AUSTRALIA, 1999, 171 (09) : 461 - 465
  • [32] Factors predicting failure of sentinel lymph node mapping in breast cancer patients with previous axillary lymph node surgery
    Tausch, C.
    Sir, A.
    Imhof, J.
    Huemer, G.
    EJC SUPPLEMENTS, 2008, 6 (07): : 149 - 149
  • [33] Predicting axillary lymph node metastases in breast carcinoma patients
    Choong, PL
    deSilva, CJS
    Dawkins, HJS
    Sterrett, GF
    Robbins, P
    Harvey, JM
    Papadimitriou, J
    Attikiouzel, Y
    BREAST CANCER RESEARCH AND TREATMENT, 1996, 37 (02) : 135 - 149
  • [34] PREDICTORS OF AXILLARY LYMPH NODE METASTASES IN WOMEN WITH BREAST CANCER
    Rodionova, M.
    Rodionov, V.
    ANNALS OF ONCOLOGY, 2012, 23 : 30 - 31
  • [35] The importance of axillary lymph node metastases in breast cancer patients
    Cerny, T
    ZENTRALBLATT FUR CHIRURGIE, 2000, 125 (10): : 813 - 816
  • [36] Diagnosis of axillary lymph node metastases in patients with breast cancer
    Noguchi, M
    Katev, N
    Miyazaki, I
    BREAST CANCER RESEARCH AND TREATMENT, 1996, 40 (03) : 283 - 293
  • [37] A Clinical-Radiomics Model for Predicting Axillary Pathologic Complete Response in Breast Cancer With Axillary Lymph Node Metastases
    Gan, Liangyu
    Ma, Mingming
    Liu, Yinhua
    Liu, Qian
    Xin, Ling
    Cheng, Yuanjia
    Xu, Ling
    Qin, Naishan
    Jiang, Yuan
    Zhang, Xiaodong
    Wang, Xiaoying
    Ye, Jingming
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [38] Cytologic diagnosis of axillary lymph node metastasis in breast cancer
    Anastasiadis, PG
    Koutlaki, NG
    Liberis, VA
    Skaphida, PG
    Tsikouras, PN
    Galazios, GC
    ACTA CYTOLOGICA, 2000, 44 (01) : 18 - 22
  • [39] Axillary schwannoma mimicking a breast cancer lymph node metastasis
    Ramdani, Hanae
    El Haddad, Siham
    Chat, Latifa
    Souadka, Abdelilah
    Allali, Nazik
    BREAST JOURNAL, 2021, 27 (04): : 387 - 388
  • [40] Significance of axillary lymph node metastasis in primary breast cancer
    Jatoi, I
    Hilsenbeck, SG
    Clark, GM
    Osborne, CK
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) : 2334 - 2340